Your browser doesn't support javascript.
loading
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma.
Rushton, Christopher K; Arthur, Sarah E; Alcaide, Miguel; Cheung, Matthew; Jiang, Aixiang; Coyle, Krysta M; Cleary, Kirstie L S; Thomas, Nicole; Hilton, Laura K; Michaud, Neil; Daigle, Scott; Davidson, Jordan; Bushell, Kevin; Yu, Stephen; Rys, Ryan N; Jain, Michael; Shepherd, Lois; Marra, Marco A; Kuruvilla, John; Crump, Michael; Mann, Koren; Assouline, Sarit; Connors, Joseph M; Steidl, Christian; Cragg, Mark S; Scott, David W; Johnson, Nathalie A; Morin, Ryan D.
Affiliation
  • Rushton CK; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Arthur SE; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Alcaide M; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
  • Cheung M; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Jiang A; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Coyle KM; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Cleary KLS; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
  • Thomas N; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Hilton LK; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Michaud N; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Daigle S; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Davidson J; Epizyme, Cambridge, MA.
  • Bushell K; Epizyme, Cambridge, MA.
  • Yu S; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Rys RN; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Jain M; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Shepherd L; McGill University, Montreal, QC, Canada.
  • Marra MA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
  • Kuruvilla J; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Crump M; Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Mann K; Princess Margaret Cancer Centre, Toronto, ON, Canada; and.
  • Assouline S; Princess Margaret Cancer Centre, Toronto, ON, Canada; and.
  • Connors JM; Lady Davis Institute for Medical Research.
  • Steidl C; Jewish General Hospital, Montreal, QC, Canada.
  • Cragg MS; Jewish General Hospital, Montreal, QC, Canada.
  • Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
  • Johnson NA; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
  • Morin RD; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Blood Adv ; 4(13): 2886-2898, 2020 07 14.
Article in En | MEDLINE | ID: mdl-32589730

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse Type of study: Prognostic_studies Limits: Humans Language: En Journal: Blood Adv Year: 2020 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse Type of study: Prognostic_studies Limits: Humans Language: En Journal: Blood Adv Year: 2020 Type: Article Affiliation country: Canada